Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Ductal, Breast | 6 | 2020 | 1100 | 0.380 |
Why?
|
| Sentinel Lymph Node Biopsy | 6 | 2022 | 710 | 0.360 |
Why?
|
| Breast Neoplasms | 17 | 2022 | 20824 | 0.350 |
Why?
|
| Carcinoma, Lobular | 4 | 2019 | 484 | 0.300 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2021 | 948 | 0.260 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2016 | 255 | 0.220 |
Why?
|
| Genes, BRCA1 | 3 | 2000 | 781 | 0.190 |
Why?
|
| Lymph Node Excision | 4 | 2022 | 1262 | 0.170 |
Why?
|
| Mastectomy | 2 | 2018 | 1793 | 0.170 |
Why?
|
| Axilla | 4 | 2022 | 597 | 0.160 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2001 | 1097 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1997 | 287 | 0.140 |
Why?
|
| Arabidopsis Proteins | 1 | 1998 | 262 | 0.140 |
Why?
|
| Lymph Nodes | 3 | 2022 | 3476 | 0.140 |
Why?
|
| Germ-Line Mutation | 5 | 2000 | 1788 | 0.130 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1997 | 431 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1997 | 473 | 0.130 |
Why?
|
| Neoplasm Proteins | 4 | 2001 | 3707 | 0.120 |
Why?
|
| Neoplasm, Residual | 1 | 2019 | 973 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 3 | 2022 | 2727 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2001 | 2850 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2018 | 1533 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 2282 | 0.080 |
Why?
|
| Breast | 3 | 2021 | 1970 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2708 | 0.080 |
Why?
|
| Ovarian Neoplasms | 3 | 2000 | 4839 | 0.080 |
Why?
|
| Neoplasm Staging | 6 | 2022 | 11031 | 0.070 |
Why?
|
| Mammaplasty | 1 | 2016 | 1204 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2000 | 12207 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2019 | 5101 | 0.060 |
Why?
|
| Lymphatic Metastasis | 3 | 2019 | 2924 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 3 | 2019 | 3616 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2022 | 3480 | 0.050 |
Why?
|
| Hyperplasia | 2 | 2021 | 1185 | 0.050 |
Why?
|
| Arylsulfotransferase | 1 | 2000 | 28 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 9240 | 0.040 |
Why?
|
| BRCA2 Protein | 3 | 2000 | 794 | 0.040 |
Why?
|
| Alleles | 3 | 2000 | 6933 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2022 | 395 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 2001 | 769 | 0.040 |
Why?
|
| Female | 19 | 2022 | 380193 | 0.040 |
Why?
|
| Genes, APC | 1 | 1999 | 159 | 0.040 |
Why?
|
| Mind-Body Therapies | 1 | 2021 | 247 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2001 | 1641 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11525 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2022 | 1032 | 0.040 |
Why?
|
| Genes, erbB-2 | 1 | 1998 | 162 | 0.040 |
Why?
|
| Penetrance | 1 | 1999 | 381 | 0.040 |
Why?
|
| Genes, myc | 1 | 1998 | 399 | 0.040 |
Why?
|
| Breast Neoplasms, Male | 1 | 1999 | 210 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 18111 | 0.040 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 1997 | 111 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8642 | 0.040 |
Why?
|
| Codon | 1 | 1998 | 611 | 0.040 |
Why?
|
| Base Sequence | 2 | 1998 | 12797 | 0.030 |
Why?
|
| Plant Proteins | 1 | 1998 | 364 | 0.030 |
Why?
|
| Exons | 2 | 2000 | 2439 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2022 | 53290 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1998 | 755 | 0.030 |
Why?
|
| Genes, ras | 1 | 1998 | 690 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1998 | 563 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2001 | 9445 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2000 | 806 | 0.030 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 1999 | 379 | 0.030 |
Why?
|
| Humans | 22 | 2022 | 744366 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2001 | 934 | 0.030 |
Why?
|
| Exercise | 2 | 2021 | 5615 | 0.030 |
Why?
|
| Methylene Blue | 1 | 2014 | 155 | 0.030 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 57776 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39052 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1525 | 0.030 |
Why?
|
| Breast Implants | 1 | 2016 | 387 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2001 | 3921 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2019 | 904 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 1997 | 1758 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2014 | 566 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 1997 | 1142 | 0.020 |
Why?
|
| Mammography | 1 | 2021 | 2475 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2021 | 77460 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 4328 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2019 | 2251 | 0.020 |
Why?
|
| Adult | 9 | 2019 | 214052 | 0.020 |
Why?
|
| Aged | 8 | 2019 | 163288 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 13814 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2001 | 13035 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2001 | 1581 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1997 | 4185 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 2949 | 0.020 |
Why?
|
| Jews | 2 | 2000 | 385 | 0.020 |
Why?
|
| Gestational Age | 1 | 2016 | 3493 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2460 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 3 | 2001 | 6171 | 0.020 |
Why?
|
| Cytokines | 1 | 2001 | 7323 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29060 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 8432 | 0.020 |
Why?
|
| Middle Aged | 7 | 2019 | 213390 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 11366 | 0.020 |
Why?
|
| Pregnancy | 2 | 2016 | 29144 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10483 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 6313 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 13693 | 0.010 |
Why?
|
| Vacuum | 1 | 2000 | 65 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 12802 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 385 | 0.010 |
Why?
|
| Histidine | 1 | 2000 | 313 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2000 | 769 | 0.010 |
Why?
|
| Cricetulus | 1 | 2001 | 818 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1161 | 0.010 |
Why?
|
| Ultrasonography, Mammary | 1 | 2000 | 250 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 1409 | 0.010 |
Why?
|
| Gene Library | 1 | 2001 | 1074 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 2000 | 536 | 0.010 |
Why?
|
| Automation | 1 | 2000 | 584 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2005 | 1002 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 2475 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 2050 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1683 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23336 | 0.010 |
Why?
|
| Arginine | 1 | 2000 | 944 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 2839 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2256 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 1999 | 684 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1999 | 802 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2000 | 981 | 0.010 |
Why?
|
| Genotype | 2 | 2000 | 12952 | 0.010 |
Why?
|
| Risk Factors | 2 | 2019 | 72296 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2001 | 1539 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 85779 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 2891 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2000 | 3508 | 0.010 |
Why?
|
| Age Distribution | 1 | 2000 | 2902 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15297 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3270 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2001 | 2715 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 4569 | 0.010 |
Why?
|
| Estrogens | 1 | 2000 | 1566 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 5181 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 40559 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4751 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 5895 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3773 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56429 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2000 | 1486 | 0.010 |
Why?
|
| Equipment Design | 1 | 2000 | 3582 | 0.010 |
Why?
|
| Heterozygote | 1 | 1999 | 2804 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2000 | 21748 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1999 | 3587 | 0.010 |
Why?
|
| Calcinosis | 1 | 2000 | 1499 | 0.010 |
Why?
|
| Pedigree | 1 | 1999 | 4642 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 5867 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63107 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15078 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2001 | 3690 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2001 | 5984 | 0.000 |
Why?
|
| DNA Methylation | 1 | 2001 | 4285 | 0.000 |
Why?
|
| Survival Analysis | 1 | 2000 | 10252 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14723 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12356 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2001 | 19233 | 0.000 |
Why?
|
| Time Factors | 1 | 2005 | 40075 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 17446 | 0.000 |
Why?
|
| Animals | 1 | 2001 | 168768 | 0.000 |
Why?
|
| Male | 1 | 1999 | 350115 | 0.000 |
Why?
|
Concepts
(164)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_